Drug Detail:Somapacitan (Somapacitan [ soe-ma-pas-i-tan ])
Drug Class: Growth hormones
Somapacitan Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because somapacitan is a large molecule that is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. However, there is no published experience with somapacitan during breastfeeding, so an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date. However, the closely related recombinant human growth hormone, somatropin, has been reported to increase milk production.
Alternate Drugs to Consider
Somatropin
Substance Identification
Substance Name
Somapacitan
CAS Registry Number
1338578-34-9
Drug Class
Breast Feeding
Lactation
Human Growth Hormone
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification